March 6, 2024

FDA Approves First Denosumab Biosimilar

The US Food and Drug Administration (FDA) has approved the first biosimilar to denosumab, denosumab-bddz (Wyost/Jubbonti). The biosimilar was also

Artificially Sweetened Drinks Increase Risk Of Irregular Heartbeat: Study

Consumption of artificially sweetened drinks raises the risk of atrial fibrillation, a heart condition that causes irregular heartbeat, a study

FDA Approves First OTC Continuous Glucose Monitor

The US Food and Drug Administration (FDA) has cleared Dexcom’s Stelo Glucose Biosensor System as the first over-the-counter continuous glucose

Study shows link between sweetened drinks and higher atrial fibrillation risk

Adults who reported drinking two liters (about 67 ounces) or more of sugar- or artificially sweetened drinks per week had

Dexcom announces its first-ever over-the-counter CGM Stelo has been cleared by the FDA

In this article DXCM Follow your favorite stocksCREATE FREE ACCOUNT The Dexcom logo is seen on a smartphone screen and

Prenatal exposure to nicotine could increase risk of behavioral disorders in newborns, study finds

Although several studies have linked smoking during pregnancy with neurodevelopmental disorders, the results of behavioral experiments in mice prenatally exposed

Lancet Menopause Series Wants to Change How Society Views ‘The Change’

Researchers warned against the “over-medicalization” of menopause in a four-paper series in The Lancet, and argued for a fresh approach

Sleep Apnea Raises Risk Of Memory And Thinking Problems: Study

Sleep apnea, a severe sleep disorder associated with various chronic health conditions such as type 2 diabetes, strokes, and heart

-